Merdler Ilan, Case Brian C, Ben-Dor Itsik, Chitturi Kalyan R, Fahey Heather, Hayat Fatima, Isaac Imad, Satler Lowell F, Rogers Toby, Waksman Ron
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC, United States of America.
Cardiovasc Revasc Med. 2025 Apr;73:8-14. doi: 10.1016/j.carrev.2024.06.021. Epub 2024 Jun 30.
BACKGROUND: Conduction disturbances have uncertain implications for long-term left ventricular ejection fraction (LVEF) after transcatheter aortic valve replacement (TAVR). We aimed to examine LVEF changes in patients up to two years post-TAVR. METHODS: We examined patients who underwent TAVR between 2012 and 2020 and underwent echocardiography follow-up. Patients were categorized into four groups: 1) Those without a permanent pacemaker (PPM) or left bundle branch block (LBBB) pre- or post-TAVR; 2) Patients with pre- and post-TAVR LBBB; 3) Individuals with preexisting PPM; and 4) Patients requiring new PPM after TAVR. LVEF was assessed at the outset of TAVR, at 30 days, 1-year, and 2-years post-TAVR. RESULTS: The study included 730 patients: 421 (57.6 %) without conduction abnormalities, 151 (20.7 %) with post-TAVR LBBB (48 pre-existing, 103 new-onset), 63 (8.6 %) with pre-existing PPM, and 95 (13.1 %) requiring new PPM. At discharge, patients without conduction abnormalities exhibited the highest LVEF (57.4 ± 11.5 %), whereas those with pre-existing PPM had the lowest (48.1 ± 15.5 %). Over two years, LVEF remained constant in patients without conduction issues and in those with pre-existing PPM. However, patients with new LBBB experienced a 6.3 % decrease in LVEF, and those requiring new PPM showed a 4.1 % reduction. CONCLUSION: New conduction abnormalities, such as LBBB or the need for PPM, induce a decline in LVEF post-TAVR. It is imperative to focus on the long-term monitoring of left ventricular function in patients experiencing new conduction disturbances post-TAVR.
背景:导管主动脉瓣置换术(TAVR)后传导障碍对长期左心室射血分数(LVEF)的影响尚不确定。我们旨在研究TAVR术后长达两年的患者LVEF变化。 方法:我们检查了2012年至2020年间接受TAVR并接受超声心动图随访的患者。患者分为四组:1)TAVR术前或术后无永久性起搏器(PPM)或左束支传导阻滞(LBBB)的患者;2)TAVR术前和术后均有LBBB的患者;3)已有PPM的个体;4)TAVR术后需要新的PPM的患者。在TAVR开始时、术后30天、1年和2年评估LVEF。 结果:该研究纳入730例患者:421例(57.6%)无传导异常,151例(20.7%)TAVR术后有LBBB(48例术前存在,103例新发),63例(8.6%)已有PPM,95例(13.1%)需要新的PPM。出院时,无传导异常的患者LVEF最高(57.4±11.5%),而已有PPM的患者LVEF最低(48.1±15.5%)。在两年时间里,无传导问题的患者和已有PPM的患者LVEF保持不变。然而,新发LBBB的患者LVEF下降了6.3%,需要新PPM的患者LVEF下降了4.1%。 结论:新的传导异常,如LBBB或需要PPM,会导致TAVR术后LVEF下降。必须关注TAVR术后出现新传导障碍患者的左心室功能长期监测。
Catheter Cardiovasc Interv. 2023-1
Circ Cardiovasc Interv. 2018-11
Cardiovasc Revasc Med. 2024-11
JACC Cardiovasc Interv. 2019-5-22
J Cardiovasc Magn Reson. 2017-2-22
Catheter Cardiovasc Interv. 2021-7-1